欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/H/0661/001
药品名称Ursodeoxycholic acid 250 mg capsules
活性成分
    • ursodeoxycholic acid 250.0 mg
剂型Hard capsule with gastro-resistant pellets
上市许可持有人MERCURY PHARMACEUTICALS LIMITED Capital House, 1st Floor, 85 King William Street, London EC4N7BL, United
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      Ursodeoxycholic acid 250 mg capsules
    • Belgium (BE)
      Ursodeoxycholic acid Amdipharm 250 mg gélules
    • Luxembourg (LU)
      Ursodeoxycholic acid amdipharm, 250 mg, Gélule
许可日期2015/12/18
最近更新日期2020/05/21
药物ATC编码
    • A05AA03 cholic acid
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase